|
|
|
Insider
Information: |
Mario Ernest |
Relationship: |
Director |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
1,151,697 |
|
Indirect Shares
|
265,510 |
|
|
Direct
Value |
$8,534,238 |
|
|
Indirect Value
|
$109,674 |
|
|
Total
Shares |
1,417,207 |
|
|
Total
Value |
$8,643,912 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-41.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 13 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CMRX |
Chimerix Inc |
Director |
|
2014-05-27 |
4 |
B |
$14.22 |
$142,200 |
D/D |
10,000 |
68,451 |
2.39 |
- |
|
VVUS |
Vivus Inc |
Director |
|
2013-05-29 |
4 |
B |
$14.68 |
$220,206 |
D/D |
15,000 |
81,125 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2013-11-25 |
4 |
B |
$15.20 |
$121,600 |
D/D |
8,000 |
46,404 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2013-11-19 |
4 |
B |
$15.25 |
$114,375 |
D/D |
7,500 |
22,564 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2013-08-30 |
4 |
B |
$15.75 |
$13,427 |
D/D |
850 |
15,064 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2013-08-29 |
4 |
B |
$15.80 |
$66,706 |
D/D |
4,214 |
14,214 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2013-08-16 |
4 |
B |
$17.45 |
$34,900 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2013-08-19 |
4 |
B |
$17.50 |
$35,000 |
D/D |
2,000 |
4,000 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2013-08-20 |
4 |
B |
$17.50 |
$700 |
D/D |
40 |
4,040 |
2.31 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2015-11-16 |
4 |
S |
$17.63 |
$2,203,163 |
D/D |
(125,000) |
86,032 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2015-05-18 |
4 |
S |
$18.09 |
$904,630 |
D/D |
(50,000) |
211,032 |
0 |
- |
|
VVUS |
Vivus Inc |
Director |
|
2012-08-20 |
4 |
B |
$20.75 |
$103,750 |
D/D |
5,000 |
45,000 |
2.39 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2006-05-10 |
4 |
B |
$21.30 |
$1,067,377 |
I/I |
50,000 |
50,000 |
2.1 |
- |
|
VVUS |
Vivus Inc |
Director |
|
2012-08-10 |
4 |
B |
$21.50 |
$107,500 |
D/D |
5,000 |
40,000 |
2.39 |
- |
|
VVUS |
Vivus Inc |
Director |
|
2012-08-09 |
4 |
B |
$21.83 |
$327,399 |
D/D |
15,000 |
35,000 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2014-09-05 |
4 |
B |
$23.19 |
$231,872 |
D/D |
10,000 |
87,254 |
2.39 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2010-08-09 |
4 |
S |
$25.12 |
$671,357 |
D/D |
(26,726) |
160,433 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2014-07-24 |
4 |
OE |
$27.69 |
$138,450 |
D/D |
5,000 |
229,358 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-02-03 |
4 |
OE |
$27.69 |
$212,272 |
D/D |
7,666 |
137,024 |
0 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2014-11-05 |
4 |
B |
$29.00 |
$290,000 |
D/D |
10,000 |
106,053 |
2.39 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-02-01 |
4 |
OE |
$29.00 |
$539,400 |
D/D |
18,600 |
101,049 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-04-26 |
4 |
OE |
$31.80 |
$158,975 |
D/D |
5,000 |
101,924 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-10-30 |
4 |
OE |
$31.80 |
$432,412 |
D/D |
13,600 |
71,024 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2011-12-05 |
4 |
D |
$33.25 |
$8,755,157 |
I/I |
(263,313) |
0 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2011-12-05 |
4 |
D |
$33.25 |
$7,140,438 |
D/D |
(214,750) |
0 |
0 |
- |
|
373 Records found
|
|
Page 13 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|